Continuum Advisory LLC Boosts Holdings in SPDR S&P Biotech ETF $XBI

Continuum Advisory LLC boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 389.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 18,013 shares of the exchange traded fund’s stock after purchasing an additional 14,330 shares during the quarter. Continuum Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $2,851,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after buying an additional 2,167 shares in the last quarter. Marshall Wace LLP boosted its position in shares of SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after acquiring an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new position in SPDR S&P Biotech ETF during the second quarter valued at $260,000. Ameriprise Financial Inc. grew its stake in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares in the last quarter. Finally, EP Wealth Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 3.7% in the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after acquiring an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $165.37 on Thursday. The company has a market cap of $10.80 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52-week low of $92.49 and a 52-week high of $169.89. The firm’s fifty day moving average is $157.76 and its two-hundred day moving average is $140.05.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.